About Granvalor Pharmaceuticals Private Limited
Data last updated:
Granvalor Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2011PTC073508. Its GSTIN is 36AAECG1832D1Z1 (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Khaja Aliuddin and Mohammed Siraj Uddin.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.14 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹6.67 Lakh (net margin 3.1%) and EBITDA of ₹10.64 Lakh (EBITDA margin 5%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 9% over five years.
The company has about 4 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Granvalor.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website granvalorpharma.com.
Company details
CIN history
Granvalor Pharmaceuticals has one previous CIN (Corporate Identification Number): U24232AP2011PTC073508. The current CIN is U24232TG2011PTC073508, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2011PTC073508 | Current |
| U24232AP2011PTC073508 | Previous |
Contact details
Granvalor Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is granvalorpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressH.No. 16 – 9 – 439/1, Malakpet, Hyderabad, Telangana, India – 500036
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Granvalor Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Granvalor Pharmaceuticals operates one associated brand: Granvalor. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Speciality in dermatology and cosmeceutical products in India. | granvalorpharma.com |
Business activity
The main business activity of Granvalor Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Granvalor Pharmaceuticals Private Limited, buy the company report.
Financials of Granvalor Pharmaceuticals Private Limited
FY 2025 filings availableGranvalor Pharmaceuticals Private Limited reported revenue of ₹2.14 Cr (up 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 22% growth in the latest year. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.64 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.67 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5% | ||||
| Net Profit Margin | 3.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Granvalor Pharmaceuticals Private Limited, buy the company report.
Board of directors of Granvalor Pharmaceuticals Private Limited
Granvalor Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Khaja Aliuddin Also directs: Valor Aluminium Private Limited | Director | 25 Mar 2011 | 15 Years 7 Months | Current |
| Mohammed Siraj Uddin | Director | 25 Mar 2011 | 15 Years 7 Months | Current |
Auditor
Granvalor Pharmaceuticals Private Limited is audited by K R BAPUJI & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K R BAPUJI & CO | FY 2022 | 000395S |
Shareholding
The shareholding of Granvalor Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Granvalor Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Granvalor Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Granvalor Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Granvalor Pharmaceuticals Private Limited has a workforce of 4 employees on its EPFO records as of Apr 10, 2024, across 1 active EPFO establishment.
GST
Granvalor Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECG1832D1Z1 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Granvalor Pharmaceuticals Private Limited, buy the company report.
Recent activity
Granvalor Pharmaceuticals Private Limited has 3 board changes on record since 2011: 2 appointments and 1 cessation. The latest: Hameda Tahseen ceased to be Director on 01 Feb 2024.
Frequently asked questions
Granvalor Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 March 2011 (15+ years old) and is registered under CIN U24232TG2011PTC073508.
Granvalor Pharmaceuticals has 2 current directors:
- Khaja Aliuddin - Director
- Mohammed Siraj Uddin - Director
The latest financial statements of Granvalor Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Granvalor Pharmaceuticals is 36AAECG1832D1Z1, registered in Telangana.
The CIN (Corporate Identification Number) of Granvalor Pharmaceuticals is U24232TG2011PTC073508. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Granvalor Pharmaceuticals was incorporated on 25 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.
Hameda Tahseen ceased to be Director on 01 Feb 2024. Khaja Aliuddin was appointed as Director on 25 Mar 2011. Mohammed Siraj Uddin was appointed as Director on 25 Mar 2011.
Granvalor Pharmaceuticals can be reached through the website granvalorpharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Granvalor Pharmaceuticals is at H.No. 16 – 9 – 4391, Malakpet, Hyderabad, Telangana, India – 500036.
Granvalor Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
